Recursion Pharmaceuticals (RXRX) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.53
-0.47
-0.41
-0.35

Details

Expected EPS
-0.377143
Actual EPS
-0.36
Surprise EPS
0.02
Surprise Percent
+4.55%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.36 per share for Q4 2025.

0 Comments

Share your thoughts